Sunshine Biopharma Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Sunshine Biopharma Inc. (SBFM) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $54.99 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-04-03
- Sunshine Biopharma Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was $54.99K, a 1.97% decline from fiscal 2024.
- Sunshine Biopharma Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2024 was $56.09K, a 1.27% decline from fiscal 2023.
- Sunshine Biopharma Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2023 was $56.81K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2025-12-31 | $54.99K 10-K · filed 2026-04-03 |
| 2024-12-31 | $56.09K 10-K · filed 2026-04-03 |
| 2023-12-31 | $56.81K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |